Objectives: To study the behavior of procalcitonin and to verify whether it can be used to differentiate children with septic conditions.
Introduction
Sepsis remains one of the greatest challenges in critical care medicine. Despite improvements in the understanding of its pathophysiology and despite new treatment options, the mortality rate continues to be elevated. 1 Several consensus conferences have been held, 2, 3 but the criteria for defining sepsis and related conditions are nevertheless still considered too sensitive and insufficiently specific, which can result in erroneous or delayed diagnoses, particularly among children. Furthermore, the clinical signs or most typical laboratory findings of sepsis occur late on, when multiple organ system failure (MOSF) has already occurred and mortality increased considerably, meaning that the effectiveness of new treatment strategies are directly related to the speed with which diagnosis is established. 3, 4 these problems with definitions and diagnosis are indications of the need to focus on biochemical mediators capable not only of distinguishing the inflammatory response to infection from other types of inflammation, but also of indicating the severity and prognosis of patients.
Procalcitonin (PCT), is a prohormone of calcitonin, normally produced by thyroid gland C-cells in response to
hypercalcemia. Under normal conditions, very low concentrations of PCT in serum (< 0.1 ng/mL) are observed. 5 More significantly, inflammatory processes induce extrathyroid production of PCT, the levels of which increase after 3 to 4
hours, peaking at around 6 hours, with a plateau of up to 24 hours, and can remain elevated for up to 48 hours. 6 the part that PCT plays as a mediator of sepsis has not yet been established. Some studies demonstrated that PCT may be useful for early diagnosis and as an indicator of severity in children with sepsis. 7, 8 However, several other studies have reported the opposite results, questioning the value of PCT for diagnosis and prognosis in patients with sepsis and septic shock. 9, 10 Furthermore, there is evidence that serum PCT levels increase in patients with Systemic Inflammatory
Response Syndrome (SIRS) of noninfectious etiology. 6 the conflicting results about the role of PCT, together with the scarcity of studies of children that have assessed this mediator, indicates that there is a need to better define its utility for the early diagnosis of sepsis in this group. Our hypothesis is that PCT is useful for both diagnosis and for assessing severity of children with septic conditions after the neonatal period.
The study objectives were: 1) to study the behavior of the serum PCT levels of children with clinical diagnoses of sepsis or septic shock and 2) to verify whether PCT was also an indicator of the severity of these patients, and of differentiating the children with diagnoses of sepsis from those with septic shock, after the neonatal period. Patients were assigned to one of two study groups on admission: sepsis group (SG) or the septic shock group (SSG). The diagnoses of sepsis or septic shock was agreed for each patient by a consensus of all researchers at weekly meetings. Since there is a possibility that a patient with sepsis will progress to septic shock, the initial diagnosis was considered the definitive criterion for assigning study group.
Methods

Patients, definitions and monitoring
Patients were monitored and given the hemodynamic support treatment recently established by a task force set up by the College of Critical Care and Society of Critical Care
Medicine. 11 the vasoactive drugs employed with shock patients, and the volumes of fluid is given during the first hour were recorded daily. MOSF was defined as the presence of at least two dysfunctional organs diagnosed according to pre-established criteria. 12 Pediatric risk of mortality (PRISM) scores were calculated for all patients at admission.
13
Laboratory tests
The first blood sample was taken on admission, and labeled T0. Once 12 hours had passed, another sample was taken and labeled T12h. The results of the biochemical analyses were not made available to the treating doctors. The blood sample taken for PCT assay was 5 mL at T0 and 3 mL on subsequent occasions, from central venous catheter. After collection, the blood was immediately refrigerated and, no more than 8 hours later, the material was centrifuged so that the mediators could be assayed in plasma.
The PCT assay was a semi-quantitative method using
GmbH, Hennigsdorf, Germany), the so-called rapid test (30 minutes). The PCT concentration classes and their possible interpretations were as follows: 6 1) < 0.5 ng/mL = sepsis unlikely, there may be a localized infection; 2) ≥ 0.5 ng/mL to < 2 ng/mL = sepsis possible; 3) ≥ 2 ng/mL to < 10 ng/mL = bacterial infection complicated by systemic inflammation; and 4) ≥ 10 ng/mL = septic shock.
Statistical analysis
Analysis of the distribution of sex, foci of infection, PCT classes by time and groups and change in PCT classes by group, was performed using the Goodman test for contrasts between multinomial populations. Evaluation of groups by age and PRISM scores was performed using the Mann-Whitney U test.
All conclusions were drawn based on a 5% significance level.
Results
Inclusion and exclusion of patients
During the period chosen for the study, 689 patients were admitted to the PICU, 59 of whom met the diagnostic criteria for sepsis and 65 of whom had septic shock. Twelve patients were excluded from the SG (six were put on antibiotics for more than 24 hours, four were postoperative patients and two had degenerative neurological diseases), and 22 were excluded from the SSG (12 were given antibiotics for more than 24 hours, three had active chronic inflammatory diseases, two had degenerative neurological diseases, two had been given corticoids and three died before samples could be taken). The final sample, therefore, comprised 90 patients, 47 in the SG and 43 in the SSG. PCT at T0 and at T12h Table 2 shows the distribution of patients across the PCT concentration classes at T0 and T12h for the two groups. At 
Comparison of groups: general characteristics
Relationship between PCT and PRISM score
It was observed that the median T0 PRISM score for the 30 patients in the SSG who were in the highest PCT class was prognostic properties than C-reactive protein, and that levels were significantly more elevated among children with septic shock than among those with sepsis, and that PCT levels were higher among patients with higher PRISM scores. Other studies have reported similar results, identifying PCT as a marker for severity in children with meningococcal sepsis 18 and in septic newborn infants, 19 in common with studies of adults. 9, 20 Luzzani et al. 21 studied 70 adults by means of daily PCT assays, demonstrating that this mediator is correlated with progression to MOSF. We were unable to establish a correlation between PCT levels and progression to MOSF.
Nevertheless, we did observe that a significantly greater proportion of SSG patients developed MOSF, when compared with the children in the SG, and also that PCT levels were more elevated in the SSG.
In a significant percentage of our septic shock patients PCT levels increased as time passed, which is behavior that may be explained by the kinetics of the mediator itself. As was described earlier, PCT peaks later, between 6 and 24 hours, reducing later, at from 2 to 3 days. 4 It is also necessary to consider the influence that antibiotic treatment has on PCT levels. Reductions in plasma concentrations of this marker have been described in response to the administration of antibiotics 22 and even that PCT might be useful for testing the response to antibiotic treatment. 23 This being so, our results may have been influenced by the use of antibiotics during the course of the disease, and this influence may have been more accentuated in less severe cases, blocking possible PCT increases in children in the SG.
There have been reports that some patients without clinical symptoms of sepsis present high PCT levels and, in contrast, that some patients who meet the clinical criteria for the disease do not have high levels of the marker.
Furthermore, that ≥ 0.5 to 2 ng/mL PCT class (sepsis possible) has been labeled the "grey zone," because of the difficulties in interpreting the result. We therefore understand that it is possible that in some of our septic patients inflammation was minimal and that others who were initially labeled as having sepsis actually had more severe systemic inflammatory conditions, 20 explaining the observation that some of the SG patients were in the PCT class that indicates septic shock and some children in the SSG were in the sepsis possible class.
These data support the statement that PCT can be 
Limitations and implications of this study
There are certain limitations to this study that merit consideration. The use of clinical diagnostic criteria may have introduced a bias to the classification of patients.
Nevertheless, since the PCT results were kept secret, the treating physicians were not influenced by them, meaning that the lack of a gold standard for diagnosis does not compromise our results. Furthermore, the influence of different classes of antibiotics on PCT levels should not be ignored, and neither should the influence of the type of organic dysfunction and the duration of the disease. With respect to this last factor, the clinical character of our research implies the possibility that patients would be at differing phases of disease progression on admission, which could also influence PCT levels. We believe that excluding children who were on antibiotics for more than 24 hours will have minimized this effect.
The reliability of a marker for sepsis/septic shock depends on the precision of clinical diagnosis, which should be sought ceaselessly in order to perfect clinical definitions, especially in children.
Conclusions
Plasma PCT levels on admission allowed sepsis and septic shock to be differentiated, with an even greater level of significance being possible after 12 hours, in the group studied here. The results suggest that PCT is valid for auxiliary diagnosis of septic conditions in children and useful as an indicator of the severity of patients. Double-blind and randomized studies are necessary before these findings can be generalized for the child population.
